This website uses cookies to improve your experience. You can accept or reject analytics cookies
Canadian Pandemic Influenza Preparedness: Planning Guidance For The Health Sector
Pandemic Preparedness and ResponseHealth Guideline2018
CanadaEnglishPDF
National
AI-Generated Document Summary
Objectives
Canadian Pandemic Influenza Preparedness: Planning Guidance for the Health Sector provides a pan-Canadian strategic framework for health-sector preparedness, response and recovery during an influenza pandemic. Its overarching goals are to minimise serious illness and deaths and to minimise societal disruption in Canada.It applies a whole-of-society, whole-of-government and risk-management approach that recognises uncertainty, varying pandemic impacts, and Canada’s geographic, demographic, cultural and socioeconomic diversity.
Reduce infection through individual and community action, public health measures, infection prevention and control, and timely risk communication.
Protect the population through safe, effective and equitable pandemic vaccination, while using antivirals for early treatment and outbreak control before vaccine becomes available.
Maintain essential health care and support services, including clinical care, primary care, emergency services, hospitals, critical care, long-term care, home care and community services.
Develop scalable surge capacity and continuity arrangements to sustain essential services and support a rapid return to normal community functioning.
Protect people at increased risk of illness or severe outcomes, including Indigenous peoples, remote and isolated communities, and people requiring tailored information, prevention, treatment, vaccination or daily-living support.
Apply ethical principles of equity, transparency, accountability, inclusiveness, proportionality, reciprocity and stewardship when allocating scarce resources or imposing public health restrictions.
Strengthen surveillance, laboratory services, research, clinical guidance, communications and information systems to support evidence-informed decisions.
The framework distinguishes the severity of illness in individual patients from population-level pandemic impact, using the latter to guide planning and proportionate response.Preparedness is designed for low- to high-impact scenarios, potentially involving multiple waves, regional variation, health-system pressure, wider social disruption and disproportionate effects on populations with limited resources or support.Planning assumptions support preparedness but are not predictions, and precautionary action may be used when evidence is initially limited.
The guidance is strategic rather than an operational response plan: its main body sets the framework, while technical annexes provide more detailed operational advice, tools and checklists.It focuses on the health sector and does not cover business continuity, overall emergency management or preparedness in non-health sectors, which remain the responsibility of relevant jurisdictions and organisations.
Implementation
Implementation rests on coordinated federal, provincial, territorial, regional and local action, with flexibility for jurisdictions to tailor plans and measures to local circumstances while retaining responsibility for their own planning and decision-making.The Public Health Agency of Canada acts as custodian of the Canadian Pandemic Influenza Plan and facilitates pan-Canadian risk assessment, while provinces and territories lead jurisdictional planning, engagement, plan activation and health-care delivery.
Coordinate health-sector emergency management through federal, provincial and territorial health ministries, supported federally by the Centre for Emergency Preparedness and Response at the Public Health Agency of Canada and linked operational centres.
Use the Federal, Provincial and Territorial Public Health Response Plan for Biological Events as a scalable governance framework connecting jurisdictional and federal response arrangements, escalation considerations and response levels.
Maintain and test pandemic and all-hazards plans, conduct training and exercises, and establish continuity, surge, stockpile, mutual-aid and information-sharing arrangements before a pandemic.
Develop memoranda of understanding and protocols to enable patient transfers, professional mobility, mutual aid, aligned messaging and prioritisation during shortages.
Integrate federal populations into provincial and territorial plans, including First Nations on reserve, active Canadian Forces members, federal inmates and specified refugee and immigration populations.
Mobilise federal surge support through the National Emergency Strategic Stockpile, federal programmes and resources, and additional medical-supply acquisition mechanisms.
Collaborate with public health authorities, health-care providers, laboratories, researchers, emergency organisations, community services, non-governmental organisations, private-sector bodies, Indigenous peoples and the public.
Response decisions should be triggered by the emergence of a novel virus and pandemic activity in Canada, rather than automatically by World Health Organization global pandemic phases.Actions may be activated, adjusted or stopped at federal, provincial, territorial, regional or local level and need not follow a linear sequence.Early action includes enhanced surveillance, intelligence gathering, risk assessment, laboratory diagnostics and communication; later action can include case management, vaccine and antiviral delivery, health-system expansion, service triage and additional public health measures where capacity is exceeded.
Surveillance builds on seasonal influenza systems and combines laboratory, hospital, sentinel-practitioner, provincial and territorial, and special-study data sources.It should track transmission, geographic spread, disease severity, hospitalisations, deaths, health-system demand, antiviral resistance, vaccine uptake, safety and effectiveness, as well as public understanding and societal impacts.Risk assessments should be conducted at pandemic onset and periodically as evidence develops, including after each wave, to inform escalation or de-escalation.
International implementation includes reporting potential events of international concern through provincial and territorial protocols to the Public Health Agency of Canada, Canada’s national focal point for the International Health Regulations (2005).Canada also collaborates with Mexico and the United States through the North American Plan for Animal and Pandemic Influenza, covering notification, surveillance, outbreak investigation, laboratory practice, countermeasures, border issues and transportation.The document does not specify a consolidated budget, costed implementation plan or quantified funding gaps.
Monitoring & Evaluation
The plan establishes a comprehensive monitoring, evaluation and learning approach for pandemic preparedness and response. It combines surveillance, laboratory intelligence, formal risk assessment, health-service data, vaccine and antiviral monitoring, public and stakeholder feedback, plan testing, and post-incident review to support decisions that are proportionate to changing pandemic impact.
Conduct initial and periodic pandemic risk assessments, including after pandemic waves, to assess transmission, viral characteristics, severity, population vulnerability, health-system and community impacts, intervention effectiveness, antiviral resistance, emerging risk factors, and the need to escalate or de-escalate measures.
Use epidemiological and laboratory surveillance to monitor geographic spread, disease trends, hospitalisations, deaths, severe illness, health-system demand, virus antigenicity, antiviral sensitivity, vaccine match and vaccine effectiveness.
Build surveillance on established seasonal influenza systems, including provincial and territorial partners, hospital networks, sentinel practitioners, laboratories, FluWatch, the Respiratory Virus Detection Surveillance System and the Global Influenza Surveillance and Response System.
Report weekly aggregate laboratory data to the National Microbiology Laboratory and share surveillance outputs through national and international influenza surveillance systems.
Monitor vaccine administration, uptake, adverse events, safety and effectiveness through vaccine registries, electronic information systems and the Canadian Adverse Events Following Immunization Surveillance System.
Monitor antiviral distribution, uptake, adverse reactions, resistance and effectiveness, including through the Canada Vigilance Program, public health laboratories and FluWatch.
Collect health-care delivery data, including hospital and intensive care admissions, ventilator use and emergency department utilisation, to identify pressure on services and guide surge measures.
Assess public health measures, infection prevention and control, clinical treatment strategies and risk communications for effectiveness, unintended consequences, proportionality and public understanding.
Track wider societal effects, including school and workplace absenteeism, supply-chain disruption, impacts on vulnerable populations, psychosocial well-being, community services and the economy.
Monitor public perceptions, concerns, information needs and trust through media monitoring, public enquiries, surveys, research and stakeholder feedback, and communicate uncertainty transparently.
Test preparedness and response plans through regular training, exercises, checklists and site visits, using after-action reports and implementation plans to address identified gaps.
Evaluate response processes, activities, decisions and outcomes, assess whether intended actions and outcomes were achieved, and develop a harmonised pan-Canadian evaluation approach across jurisdictions.
Review the main plan and technical annexes every five years, with interim updates where necessary to incorporate evidence, best practice, scientific advances and lessons from pandemic responses.
Maintain accountability through federal ministerial responsibility to Parliament for risk identification, emergency plans, plan maintenance and testing, exercises and training, while supporting open, publicly accessible and consultative decision-making.
Named accountability and reporting mechanisms include provincial and territorial notification protocols to the Public Health Agency of Canada, Canada's national focal point for International Health Regulations matters, and notification to the World Health Organization of qualifying potential public health emergencies of international concern.The plan does not specify a single consolidated indicator framework, universal performance targets, reporting timetable, audit process or evaluation template.
Costing & Financing
The plan identifies substantial preparedness and response resource needs, but does not provide a costed budget, expenditure amounts, funding allocations, quantified funding gaps, financing sources or economic assumptions.
Maintain resource arrangements for pandemic vaccine procurement, including a ten-year Canadian supply contract for domestically produced adjuvanted vaccine and a secondary vaccine supply.
Maintain national antiviral stockpiles, comprising the provincially and territorially managed National Antiviral Stockpile and the federally owned National Emergency Strategic Stockpile for surge capacity.
Mobilise federal supplies, equipment, programmes, employees and other resources, and facilitate additional medical-supply acquisition through Public Services and Procurement Canada and other federal agencies.
Provide medications, supplies and equipment for federal populations through established federal, provincial and territorial distribution and administration systems.
Develop and maintain surge capacity, continuity arrangements, stockpiles, strategic equipment reserves, staffing, volunteers, space, personal protective equipment, laboratory capacity and electronic information systems.
Establish advance funding arrangements and identify sustained funding sources for rapid pandemic research, alongside protocols and rapid ethics-review processes.
Resource prioritisation is guided by equitable access to vaccines, antiviral medicines and other essential health resources, particularly where supply is delayed or insufficient.The plan recognises that restrictive public health measures, such as proactive school closures and travel restrictions, can create significant societal and economic costs, and that high-impact scenarios may disrupt productivity, basic services and supply chains.No monetary valuation or quantified economic impact is supplied.